18361-50-7 Usage
Uses
Used in Pharmaceutical Industry:
Leukomycin A8 is used as an anticancer agent for its ability to selectively target and inhibit the growth of cancer cells. It is particularly effective in inducing cell cycle arrest and apoptosis, which are critical for controlling tumor progression.
Used in Cancer Research:
In the field of cancer research, Leukomycin A8 serves as a valuable tool for studying the molecular mechanisms underlying cancer cell growth and survival. Its impact on key signaling pathways provides insights into potential therapeutic targets for cancer treatment.
Used in Drug Development:
Leukomycin A8 is utilized in the development of novel anticancer drugs due to its potent activity against various types of cancer cells. Its selectivity and mechanism of action offer a promising foundation for creating more effective and targeted cancer therapies.
Used in Combination Therapy:
Leukomycin A8 is also considered for use in combination therapies with other anticancer agents. Its ability to target specific pathways in cancer cells may enhance the effectiveness of existing treatments and overcome resistance issues in cancer therapy.
Check Digit Verification of cas no
The CAS Registry Mumber 18361-50-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,8,3,6 and 1 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 18361-50:
(7*1)+(6*8)+(5*3)+(4*6)+(3*1)+(2*5)+(1*0)=107
107 % 10 = 7
So 18361-50-7 is a valid CAS Registry Number.
InChI:InChI=1/C39H63NO15/c1-21-18-27(16-17-41)35(36(48-10)29(52-25(5)42)19-30(45)49-22(2)14-12-11-13-15-28(21)44)55-38-33(46)32(40(8)9)34(23(3)51-38)54-31-20-39(7,47)37(24(4)50-31)53-26(6)43/h11-13,15,17,21-24,27-29,31-38,44,46-47H,14,16,18-20H2,1-10H3/b12-11+,15-13+/t21-,22-,23-,24+,27+,28+,29-,31+,32-,33-,34-,35+,36+,37+,38+,39-/m1/s1
